Staphylococcus aureus surgical site infection rates in 5 European countries
-
Published:2023-09-19
Issue:1
Volume:12
Page:
-
ISSN:2047-2994
-
Container-title:Antimicrobial Resistance & Infection Control
-
language:en
-
Short-container-title:Antimicrob Resist Infect Control
Author:
Mellinghoff Sibylle C.ORCID, Bruns Caroline, Albertsmeier MarkusORCID, Ankert JulianeORCID, Bernard LouisORCID, Budin Sofia, Bataille CamilleORCID, Classen Annika Y.ORCID, Cornely Florian B., Couvé-Deacon ElodieORCID, Fernandez Ferrer Maria, Fortún JesúsORCID, Galar AliciaORCID, Grill Eva, Guimard Thomas, Hampl Jürgen A., Wingen-Heimann SebastianORCID, Horcajada Juan P.ORCID, Köhler Felix, Koll Carolin, Mollar Joan, Muñoz PatriciaORCID, Pletz Mathias W., Rutz Jule, Salmanton-García Jon, Seifert Harald, Serracino-Inglott FerdinandORCID, Soriano Alex, Stemler JannikORCID, Vehreschild Janne J.ORCID, Vilz Tim O.ORCID, Naendrup Jan-HendrikORCID, Cornely Oliver A.ORCID, Liss Blasius J.ORCID
Abstract
Abstract
Objective
To determine the overall and procedure-specific incidence of surgical site infections (SSI) caused by Staphylococcus aureus (S. aureus) as well as risk factors for such across all surgical disciplines in Europe.
Methods
This is a retrospective cohort of patients with surgical procedures performed at 14 European centres in 2016, with a nested case–control analysis. S. aureus SSI were identified by a semi-automated crossmatching bacteriological and electronic health record data. Within each surgical procedure, cases and controls were matched using optimal propensity score matching.
Results
A total of 764 of 178 902 patients had S. aureus SSI (0.4%), with 86.0% of these caused by methicillin susceptible and 14% by resistant pathogens. Mean S. aureus SSI incidence was similar for all surgical specialties, while varying by procedure.
Conclusions
This large procedure-independent study of S. aureus SSI proves a low overall infection rate of 0.4% in this cohort. It provides proof of principle for a semi-automated approach to utilize big data in epidemiological studies of healthcare-associated infections.
Trials registration The study was registered at clinicaltrials.gov under NCT03353532 (11/2017).
Funder
Universitätsklinikum Köln
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health
Reference25 articles.
1. European centre for disease prevention and control. Surveillance of surgical site infections and prevention indicators in European hospitals - HAI-Net SSI protocol, version 2.2. Stockholm: ECDC; 2017. 2017. 2. Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, Goossens MM, Vaerenberg S, Hopkins S, Catry B, Monnet DL. The European centre for disease prevention and control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Eurosurveillance. 2012;17(46):20316. 3. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37(5):387–97. 4. https://www.ecdc.europa.eu/sites/default/files/documents/HAI-Net-SSI-protocol-v2.2.pdf 2021. 5. Chang BH, Hsu YJ, Rosen MA, Gurses AP, Huang S, Xie A, et al. Reducing three infections across cardiac surgery programs: a multisite cross-unit collaboration. Am J Med Qual. 2020;35(1):37–45.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|